Zoetis (ZTS) Cash from Operations (2012 - 2026)
Zoetis (ZTS) posted quarterly Cash from Operations of 401000000.0 for Q1 2026, down 22.14% year-over-year from 515000000.0 in Q1 2025, and down 55.1% quarter-over-quarter from 893000000.0 in Q4 2025.
Zoetis (ZTS) Cash from Operations (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Cash from Operations for 15 consecutive years, with 401000000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations fell 22.14% year-over-year to 401000000.0; the TTM figure through Mar 2026 stood at 2790000000.0 (down 2.89% YoY), while the FY2025 annual figure was 2904000000.0, down 1.66% from the prior year.
- Cash from Operations fell to 401000000.0 in Q1 2026 per ZTS's latest filing, from 893000000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 951000000.0 in Q3 2024 and bottomed at 183000000.0 in Q2 2023.
- Historically, Cash from Operations has averaged 619000000.0 across 5 years, with a median of 558000000.0 in 2025.
- Annual changes were most pronounced in 2023 — Cash from Operations sank 45.54% — and 2024, when it jumped 174.32%.
- Zoetis' Cash from Operations stood at 741000000.0 in 2022, then grew by 21.05% to 897000000.0 in 2023, then grew by 0.89% to 905000000.0 in 2024, then dropped by 1.33% to 893000000.0 in 2025, then plunged by 55.1% to 401000000.0 in 2026.
- Business Quant data shows ZTS's Cash from Operations at 401000000.0 in Q1 2026, 893000000.0 in Q4 2025, and 938000000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 145.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 655.00 Mn |
| Jun 30, 2026 | 655.00 Mn |
| Mar 31, 2026 | 401.00 Mn |
| Mar 31, 2026 | 401.00 Mn |
| Dec 31, 2025 | 893.00 Mn |
| Dec 31, 2025 | 893.00 Mn |
| Sep 30, 2025 | 938.00 Mn |
| Sep 30, 2025 | 938.00 Mn |
| Jun 30, 2025 | 558.00 Mn |
| Jun 30, 2025 | 558.00 Mn |
| Mar 31, 2025 | 515.00 Mn |
| Mar 31, 2025 | 515.00 Mn |
| Dec 31, 2024 | 905.00 Mn |
| Dec 31, 2024 | 905.00 Mn |
| Sep 30, 2024 | 951.00 Mn |
| Sep 30, 2024 | 951.00 Mn |
| Jun 30, 2024 | 502.00 Mn |
| Jun 30, 2024 | 502.00 Mn |
| Mar 31, 2024 | 595.00 Mn |
| Mar 31, 2024 | 595.00 Mn |